Abstract
In type 1 diabetes, a failure in the regulation of either innate or acquired immunity may be the cause of autoimmune response. A cell population that may have a regulatory role of the immune response are the Natural Killer T (NKT) cells, which are a population expressing T lymphocyte antigen receptor (TCR), and a common marker for NK cells. A distinctive characteristic in NKT cells is their capacity to produce large amounts of immune-modulating cytokines. A decrease in the number and/or functional incapability of NKT cells is associated with progression of type 1 diabetes and with other self-immune diseases. However, the relevance of such findings is not completely understood. Limitations of the current studies include the existing methods to measure NKT activation and the lack of assessment of the expression of genes affected by NKT action. Nevertheless, the study of NKT cells may be a new clinical approach to detect individuals at risk for having type 1 diabetes. Additional studies are needed to evaluate the clinical value of this new predictive tool.
Keywords: Natural Killer T (NKT) cells, Type 1 diabetes, Class-I MHC-restricted T-cell associated molecule (CRTAM), T lymphocyte antigen receptor (TCR), Effector lymphocytes, Human Leukocytary Antigen (HLA), Tumor Necrosis Factor, Insulitis, Hyperglycemia, Immunoglobulin
Current Diabetes Reviews
Title: The Role of Natural Killer T (NKT) Cells in the Pathogenesis of Type 1 Diabetes
Volume: 7 Issue: 4
Author(s): Rita A. Gomez-Diaz, Mayra V. Aguilar, Elisa N. Meguro, Rocio H. Marquez, Eulalia G. Magana, M. Carmen Martinez-Garcia, Niels W. Rodarte, Carlos A. Aguilar-Salinas, Elsy Canche-Pool and Vianney Ortiz-Navarrete
Affiliation:
Keywords: Natural Killer T (NKT) cells, Type 1 diabetes, Class-I MHC-restricted T-cell associated molecule (CRTAM), T lymphocyte antigen receptor (TCR), Effector lymphocytes, Human Leukocytary Antigen (HLA), Tumor Necrosis Factor, Insulitis, Hyperglycemia, Immunoglobulin
Abstract: In type 1 diabetes, a failure in the regulation of either innate or acquired immunity may be the cause of autoimmune response. A cell population that may have a regulatory role of the immune response are the Natural Killer T (NKT) cells, which are a population expressing T lymphocyte antigen receptor (TCR), and a common marker for NK cells. A distinctive characteristic in NKT cells is their capacity to produce large amounts of immune-modulating cytokines. A decrease in the number and/or functional incapability of NKT cells is associated with progression of type 1 diabetes and with other self-immune diseases. However, the relevance of such findings is not completely understood. Limitations of the current studies include the existing methods to measure NKT activation and the lack of assessment of the expression of genes affected by NKT action. Nevertheless, the study of NKT cells may be a new clinical approach to detect individuals at risk for having type 1 diabetes. Additional studies are needed to evaluate the clinical value of this new predictive tool.
Export Options
About this article
Cite this article as:
A. Gomez-Diaz Rita, V. Aguilar Mayra, N. Meguro Elisa, H. Marquez Rocio, G. Magana Eulalia, Carmen Martinez-Garcia M., W. Rodarte Niels, A. Aguilar-Salinas Carlos, Canche-Pool Elsy and Ortiz-Navarrete Vianney, The Role of Natural Killer T (NKT) Cells in the Pathogenesis of Type 1 Diabetes, Current Diabetes Reviews 2011; 7 (4) . https://dx.doi.org/10.2174/157339911796397839
DOI https://dx.doi.org/10.2174/157339911796397839 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mild Carbohydrate Intolerance in Pregnancy
Current Diabetes Reviews Hyperuricaemia and Non-Alcoholic Fatty Liver Disease (NAFLD): A Relationship with Implications for Vascular Risk?
Current Vascular Pharmacology A Chemical Genetics Approach for Specific Differentiation of Stem Cells to Somatic Cells: A New Promising Therapeutical Approach
Combinatorial Chemistry & High Throughput Screening Statins as Anti-Inflammatory Agents in Atherogenesis: Molecular Mechanisms and Lessons from the Recent Clinical Trials
Current Pharmaceutical Design Local Drug Delivery Based Treatment Approaches for Effective Management of Periodontitis
Current Drug Therapy Treatments for Hypertension in Type 2 Diabetes-Non-pharmacological and Pharmacological Measurements<sup>#</sup>
Current Hypertension Reviews Immunological Aspects of the Prostate Gland and Related Diseases
Current Immunology Reviews (Discontinued) The Role of Intravascular Ultrasound to Guide Drug-Eluting Stents Implantation
Cardiovascular & Hematological Agents in Medicinal Chemistry Clinical Significance of Pleiotropic Effects of Statins: Lipid Reduction and Beyond
Current Medicinal Chemistry The Application of Stimuli-responsive Nanocarriers for Targeted Drug Delivery
Current Topics in Medicinal Chemistry A Lack of Association Between Blood Glutamate and Anxiety Levels in Pre- delivery Pregnant Women
Current Pharmaceutical Analysis Inhaled Corticosteroids in COPD: Pros and Cons
Current Drug Targets Modification Strategies of Lipid-Based Nanocarriers for Mucosal Drug Delivery
Current Pharmaceutical Design Role of the Autonomic Nervous System in the Endothelial Dysfunction of the Metabolic Syndrome
Current Hypertension Reviews Beneficial Effects of Vildagliptin on Metabolic Parameters in Patients with Type 2 Diabetes
Endocrine, Metabolic & Immune Disorders - Drug Targets High Density Lipoprotein – Should we Raise it?
Current Vascular Pharmacology Inhibitors of HMG-CoA Reductase: Current and Future Prospects
Mini-Reviews in Medicinal Chemistry Aldose Reductase Inhibition: Emerging Drug Target for the Treatment of Cardiovascular Complications
Recent Patents on Cardiovascular Drug Discovery Endothelial Dysfunction in Hyperglycemia as a Trigger of Atherosclerosis
Current Diabetes Reviews Gestational Diabetes and the Metabolic Syndrome: Can Obesity and Small, Dense Low Density Lipoproteins be Key Mediators of this Association?
Current Pharmaceutical Biotechnology